{{Rsnum
|rsid=11179002
|Gene=TPH2
|Chromosome=12
|position=71948504
|Orientation=plus
|GMAF=0.3205
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=TPH2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 57.8 | 35.9 | 6.2
| HCB | 34.1 | 54.5 | 11.4
| JPT | 36.4 | 36.4 | 27.3
| YRI | 46.0 | 49.2 | 4.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 34.1 | 54.5 | 11.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11179002
|Name_s=
|Gene_s=TPH2
|Feature=
|Evidence=PubMed ID:19125159
|Annotation=In a case-control study consisting of 998 patients with recurrent unipolar depression (RUD) and 1023 psychiatric healthy controls this variant in an intron region of the TPH2 gene showed significant association with the rate of metabolic syndrome.
|Drugs=
|Drug Classes=
|Diseases=Depression; metabolic syndrome
|Curation Level=Curated
|PharmGKB Accession ID=PA163367829
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11179002
|overall_frequency_n=23
|overall_frequency_d=120
|overall_frequency=0.191667
|n_genomes=18
|n_genomes_annotated=0
|n_haplomes=20
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}